Menu

AONN+ Acuity Tool: Where Are We Now?

September 12, 2019 | Video Library | Acuity, Research/Quality/Performance Improvement, Barriers to Care
Featuring:
Cheryl Bellomo, MSN, RN, HON-ONN-CG, OCN
Cheryl Bellomo, MSN, RN, HON-ONN-CG, OCN
Oncology Nurse Navigator
Intermountain Cancer Center Cedar City Hospital
Cedar City, Utah
Wendy Latash, PhD
Wendy Latash, PhD
Patient Experience and Outcomes; Senior Manager Medical Education Astellas Pharma US Northbrook, Illinois
Danelle Johnston, MSN, RN, HON-ONN-CG, OCN
Danelle Johnston, MSN, RN, HON-ONN-CG, OCN
Senior Vice President, Education, Learning & Innovation
Cancer Support Community
Wendy Latash, PhD, provides an overview on the current status and future plans for the AONN+ Acuity Tool.
Related Articles
3 Strategies to Address Transportation Barriers for Patients with Cancer
Mu Lin
July 11, 2022 | AONN+ Blog | Barriers to Care
Transportation barriers particularly affect patients with cancer who need timely access to care. Read on for strategies to address these barriers as presented at the 2022 AONN+ Midyear Conference.
6-Month LHRH Formulations Are a Good Choice During the COVID-19 Pandemic and Beyond
Tina DeNofrio, RN, BSN, OCN, Stuart N. Atkinson, MB, ChB, Deborah M. Boldt-Houle, PhD
December 17, 2021 | November 2021 Vol 12, No 11 | Research/Quality/Performance Improvement
Prostate cancer (PCa) patients treated with injectable androgen deprivation therapy (ADT) are particularly vulnerable during a pandemic because they may not be able to self-administer treatment and may be required to visit a clinic/hospital for injections.
A Virtual Prostate Cancer Clinic for Follow-Up Care: A Digital Health Platform Creates Efficient Navigation and Care Coordination Benefiting Survivors, Provider, and the Healthcare System
Richard N. Boyajian, Ashleigh M. Kowtoniuk, PA, APRN-NP, Krystle R. Boyajian, Mark J. Mackin, MBA, RT(T)
December 17, 2021 | November 2021 Vol 12, No 11 | Research/Quality/Performance Improvement
Prostate cancer is the most common male malignancy. In 2021, the United States will see an estimated 248,530 new cases, 34,130 deaths, and more than 3 million survivors.

Thank You to Our Corporate Sponsors and Alliance Partners!

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • National Alliance Partner

    National Alliance Partner

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • National Alliance Partner

    National Alliance Partner

  • National Alliance Partner

    National Alliance Partner